Aura Biosciences (AURA) Return on Capital Employed (2021 - 2026)
Aura Biosciences (AURA) posted Return on Capital Employed of 86.68% for Q1 2026, down 24.0% on a QoQ basis from 69.91% in Q4 2025, and down 2109.0% year-over-year from 4.31% in Q1 2025.
Aura Biosciences (AURA) Return on Capital Employed (2021 - 2026) Analysis & Trends
Aura Biosciences' Return on Capital Employed history runs 6 years deep, the most recent figure standing at 86.68% for Q1 2026.
- Quarterly Return on Capital Employed fell 2109.0% year-over-year to 86.68% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 86.68% (down 2109.0% YoY) and the FY2025 annual result came in at 71.58%, down 2443.0% from the prior year.
- Return on Capital Employed was 86.68% for Q1 2026 at Aura Biosciences, down from 69.91% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 28.43% in Q1 2022 and bottomed at 86.68% in Q1 2026.
- A 5-year average of 48.74% and a median of 42.06% in 2022 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2023 — Return on Capital Employed plunged 232 bps — and 2025, when it sank 2826 bps.
- Aura Biosciences' Return on Capital Employed stood at 34.84% in 2022, then dropped by 19 bps to 41.45% in 2023, then dropped by 30 bps to 53.69% in 2024, then slumped by 30 bps to 69.91% in 2025, then retreated by 24 bps to 86.68% in 2026.
- Business Quant data shows AURA's Return on Capital Employed at 86.68% in Q1 2026, 69.91% in Q4 2025, and 63.55% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -31.80% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.46% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -68.47% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 21.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 10.19% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -68.84% |
| 10 | Aura Biosciences | 485.62 Mn | 400.83 Mn | - | -86.68% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -86.68% |
| Dec 31, 2025 | -69.91% |
| Sep 30, 2025 | -63.55% |
| Jun 30, 2025 | -65.85% |
| Mar 31, 2025 | -65.59% |
| Dec 31, 2024 | -53.69% |
| Sep 30, 2024 | -47.23% |
| Jun 30, 2024 | -41.81% |
| Mar 31, 2024 | -37.33% |
| Dec 31, 2023 | -41.45% |
| Sep 30, 2023 | -44.38% |
| Jun 30, 2023 | -38.53% |
| Mar 31, 2023 | -32.35% |
| Dec 31, 2022 | -34.84% |
| Sep 30, 2022 | -42.06% |
| Jun 30, 2022 | -34.95% |
| Mar 31, 2022 | -28.43% |
| Dec 31, 2021 | -29.87% |